...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>European journal of paediatric neurology: EJPN : official journal of the European Paediatric Neurology Society >The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.
【24h】

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

机译：关于使用肉毒杆菌毒素治疗脑瘫儿童的2009年欧洲共识更新。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

An interdisciplinary European group of clinical experts in the field of movement disorders and experienced Botulinum toxin users has updated the consensus for the use of Botulinum toxin in the treatment of children with cerebral palsy (CP). A problem-orientated approach was used focussing on both published and practice-based evidence. In part I of the consensus the authors have tabulated the supporting evidence to produce a concise but comprehensive information base, pooling data and experience from 36 institutions in 9 European countries which involves more than 10,000 patients and over 45,000 treatment sessions during a period of more than 280 treatment years. In part II of the consensus the Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS) based Motor Development Curves have been expanded to provide a graphical framework on how to treat the motor disorders in children with CP. This graph is named "CP(Graph) Treatment Modalities - Gross Motor Function" and is intended to facilitate communication between parents, therapists and medical doctors concerning (1) achievable motor function, (2) realistic goal-setting and (3) treatment perspectives for children with CP. The updated European consensus 2009 summarises the current understanding regarding an integrated, multidisciplinary treatment approach using Botulinum toxin for the treatment of children with CP.
机译：欧洲运动疾病领域的跨学科临床专家小组和经验丰富的肉毒杆菌毒素使用者更新了使用肉毒杆菌毒素治疗儿童脑瘫（CP）的共识。使用了一种以问题为导向的方法，重点放在已发布的证据和基于实践的证据上。在共识的第一部分中，作者汇总了支持的证据，以建立一个简洁而全面的信息库，汇集了来自9个欧洲国家/地区的36个机构的数据和经验，涉及超过10,000名患者和超过45,000疗程， 280年治疗。在共识的第二部分中，已扩展了基于总运动功能量度（GMFM）和基于总运动功能分类系统（GMFCS）的运动发展曲线，以提供有关如何治疗CP儿童运动障碍的图形框架。此图被称为“ CP（图）治疗方式-运动功能总状况”，旨在促进父母，治疗师和医生之间的交流，涉及以下方面：（1）可实现的运动功能，（2）现实的目标设定和（3）治疗观点对于患有CP的儿童。最新的《 2009年欧洲共识》总结了当前对使用肉毒杆菌毒素治疗CP儿童的综合，多学科治疗方法的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号